Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

profileRodney Howard Falk, M.D.

TitleAssociate Professor of Medicine, Part-time
InstitutionBrigham and Women's Hospital
DepartmentMedicine
AddressHarvard Vanguard Medical Associates
133 Brookline Ave
Boston MA 02215
Phone617/421-6050
vCardDownload vCard (login for email)

Collapse Research 
Collapse research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
R01HL130563     (DORBALA, SHARMILA)Apr 1, 2016 - Mar 31, 2020
NIH/NHLBI
Molecular Imaging of Primary Amyloid Cardiomyopathy
Role: Co-Principal Investigator

M01RR000533     (ANTMAN, KAREN)Dec 1, 1978 - Nov 30, 2011
NIH/NCRR
General Clinical Research Center
Role: Co-Principal Investigator

Collapse Bibliographic 
Collapse selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Alexander KM, Singh A, Falk RH. Novel pharmacotherapies for cardiac amyloidosis. Pharmacol Ther. 2017 Jun 22. PMID: 28648829.
    View in: PubMed
  2. Nochioka K, Quarta CC, Claggett B, Roca GQ, Rapezzi C, Falk RH, Solomon SD. Left atrial structure and function in cardiac amyloidosis. Eur Heart J Cardiovasc Imaging. 2017 Jun 16. PMID: 28637305.
    View in: PubMed
  3. Singh A, Geller HI, Falk RH. Val122Ile mt-ATTR Has a Worse Survival Than wt-ATTR Cardiac Amyloidosis. J Am Coll Cardiol. 2017 Feb 14; 69(6):757-758. PMID: 28183520.
    View in: PubMed
  4. Divakaran S, Singh A, Collins B, Vita T, Falk RH, Di Carli MF, Blankstein R. Role of Imaging in Evaluating Infiltrative Heart Disease. Curr Treat Options Cardiovasc Med. 2017 Jan; 19(1):3. PMID: 28150064.
    View in: PubMed
  5. Kassop D, Nam JJ, Cebula BR, Shah P, Blankstein R, Falk RH, Hulten EA. A tale of two diagnoses: The role of noninvasive cardiovascular imaging to differentiate cardiac amyloidosis. J Nucl Cardiol. 2016 Nov 08. PMID: 27826773.
    View in: PubMed
  6. Falk RH, Alexander KM, Liao R, Dorbala S. AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy. J Am Coll Cardiol. 2016 Sep 20; 68(12):1323-41. PMID: 27634125.
    View in: PubMed
  7. Alexander KM, Falk RH. V122I TTR Cardiac Amyloidosis in Patients of African Descent: Recognizing a Missed Disease or the Dog That Didn't Bark? Circ Heart Fail. 2016 Sep; 9(9). PMID: 27618856.
    View in: PubMed
  8. Sivakumar S, Taccone FS, Desai KA, Lazaridis C, Skarzynski M, Sekhon M, Henderson W, Griesdale D, Chapple L, Deane A, Williams L, Strickland R, Lange K, Heyland D, Chapman M, Rowland MJ, Garry P, Westbrook J, Corkill R, Antoniades CA, Pattinson KT, Fatania G, Strong AJ, Myers RB, Lazaridis C, Jermaine CM, Robertson CS, Rusin CG, Hofmeijer J, Sondag L, Tjepkema-Cloostermans MC, Beishuizen A, Bosch FH, van Putten MJ, Carteron L, Patet C, Solari D, Oddo M, Ali MA, Dias C, Almeida R, Vaz-Ferreira A, Silva J, Monteiro E, Cerejo A, Rocha AP, Elsayed AA, Abougabal AM, Beshey BN, Alzahaby KM, Pozzebon S, Ortiz AB, Cristallini S, Lheureux O, Brasseur A, Vincent JL, Creteur J, Taccone FS, Hravnak M, Yousef K, Chang Y, Crago E, Friedlander RM, Abdelmonem SA, Tahon SA, Helmy TA, Meligy HS, Puig F, Dunn-Siegrist I, Pugin J, Gupta S, Govil D, Srinivasan S, Patel SJ, N JK, Gupta A, Tomar DS, Shafi M, Harne R, Arora DP, Talwar N, Mazumdar S, Papakrivou EE, Makris D, Manoulakas E, Tsolaki B, Karadodas B, Zakynthinos E, Garcia IP, Martin AD, Encinares VS, Ibañez MP, Montero JG, Labrador G, Cangueiro TC, Poulose V, Koh J, Kam JW, Yeter H, Kara A, Aktepe O, Topeli A, Tsolakoglou I, Intas G, Stergiannis P, Kolaros AA, Chalari E, Athanasiadou E, Martika A, Fildisis G, Faivre V, Mengelle C, Favier B, Payen D, Poppe A, Winkler MS, Mudersbach E, Schreiber J, Wruck ML, Schwedhelm E, Kluge S, Zöllner C, Tavladaki T, Spanaki AM, Dimitriou H, Kondili E, Choulaki C, Meleti E, Kafetzopoulos D, Georgopoulos D, Briassoulis G, la Torre AG, de la Torre-Prados MV, Tsvetanova-Spasova T, Nuevo-Ortega P, Rueda-Molina C, Fernández-Porcel A, Camara-Sola E, Salido-Díaz L, García-Alcántara A, Tavladaki T, Spanaki AM, Dimitriou H, Kondili E, Choulaki C, Meleti DE, Kafetzopoulos D, Georgopoulos D, Briassoulis G, Suberviola B, Riera J, Rellan L, Sanchez M, Robles JC, Lopez E, Vicente R, Miñambres E, Santibañez M, Le Guen M, Moore J, Mason N, Windpassinger M, Plattner O, Mascha E, Sessler DI, Research O, Melia U, Fontanet J, van den Berg JP, Struys MM, Vereecke HE, Jensen EW, Rood PJ, van de Schoor F, van Tertholen K, Pickkers P, van den Boogaard M, Beardow ZJ, Redhead H, Paramasivam K, Numan T, van den Boogaard M, Kamper AM, Rood P, Peelen LM, Zeman PM, Slooter AJ, van Ewijk CE, Jacobs GE, Girbes AR, Myatra SN, Harish MM, Prabu NR, Siddiqui S, Kulkarni AP, Divatia JV, Murbach LD, Leite MA, Osaku EF, Costa CR, Pelenz M, Neitzke NM, Moraes MM, Jaskowiak JL, Silva MM, Zaponi RS, Abentroth LR, Ogasawara SM, Jorge AC, Duarte PA, Hernández-Sánchez N, Sánchez-Hurtado LA, García-Guillen FJ, Ñamendys-Silva SA, Maghsoudi B, Emami M, Khosravi MB, Zand F, Tabatabaie HR, Masjedi M, Sabetiyan G, Mokri A, Troubleyn J, Diltoer M, Jacobs R, Nguyen DN, De Waele E, De Regt J, Honoré PM, Van Gorp V, Spapen HD, Contreras RS, Toapanta ND, Moreno G, Sabater J, Torrado H, Gonzalez M, Marin M, Farigola E, Gonzalez A, Fernandez J, Vera A, Gisbert X, Juliá C, Uya J, Corral L, Elias-Jones I, Gemmell L, MacKay A, Randall D, Adwaney A, Blunden M, Prowle JR, Kirwan CJ, Thomas N, Martin A, Owen H, Darwin L, Conway D, Atkinson D, Sharman M, Moore J, Barbanti C, Amour J, Gaudard P, Rozec B, Mauriat P, M'rini M, Leger PL, Cambonie G, Liet JM, Girard C, Laroche S, Damas P, Assaf Z, Loron G, Lecourt L, Pouard P, Randall D, Adwaney A, Blunden M, Prowle JR, Kirwan CJ, Kim SH, Na S, Kim J, Oh SY, Jung CW, Yoo SH, Min SH, Chung EJ, Lee H, Lee NJ, Lee KW, Suh KS, Ryu HG, Marshall DC, Goodson RJ, Salciccioli JD, Shalhoub J, Potter EK, Kirk-Bayley J, Karanjia ND, Forni LG, Creagh-Brown BC, Bossy M, Nyman M, Tailor A, Creagh-Brown B, D'Antini D, Spadaro S, Valentino F, Sollitto F, Cinnella G, Mirabella L, Calvo FJ, Bejarano N, Padilla D, Baladron V, Villajero P, Villazala R, Redondo J, Yuste AS, Liu J, Shen F, Teboul JL, Anguel N, Beurton A, Bezaz N, Richard C, Monnet X, Fossali T, Colombo R, Ottolina D, Rossetti M, Mazzucco C, Marchi A, Porta A, Catena E, Tollisen KH, Andersen GØ, Heyerdahl F, Jacobsen D, et al. ESICM LIVES 2016: part two : Milan, Italy. 1-5 October 2016. Intensive Care Med Exp. 2016 Sep; 4(Suppl 1):30. PMID: 27686460.
    View in: PubMed
  9. Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, Wechalekar AD, Berk JL, Quarta CC, Grogan M, Lachmann HJ, Bokhari S, Castano A, Dorbala S, Johnson GB, Glaudemans AW, Rezk T, Fontana M, Palladini G, Milani P, Guidalotti PL, Flatman K, Lane T, Vonberg FW, Whelan CJ, Moon JC, Ruberg FL, Miller EJ, Hutt DF, Hazenberg BP, Rapezzi C, Hawkins PN. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis. Circulation. 2016 Jun 14; 133(24):2404-12. PMID: 27143678.
    View in: PubMed
  10. Falk RH. Pondering the Prognosis and Pathology of Cardiac Amyloidosis: Answers Breed Questions. JACC Cardiovasc Imaging. 2016 Feb; 9(2):139-41. PMID: 26777215.
    View in: PubMed
  11. Barbhaiya CR, Kumar S, Baldinger SH, Michaud GF, Stevenson WG, Falk R, John RM. Electrophysiologic assessment of conduction abnormalities and atrial arrhythmias associated with amyloid cardiomyopathy. Heart Rhythm. 2016 Feb; 13(2):383-90. PMID: 26400855.
    View in: PubMed
  12. Park MA, Padera RF, Belanger A, Dubey S, Hwang DH, Veeranna V, Falk RH, Di Carli MF, Dorbala S. 18F-Florbetapir Binds Specifically to Myocardial Light Chain and Transthyretin Amyloid Deposits: Autoradiography Study. Circ Cardiovasc Imaging. 2015 Aug; 8(8). PMID: 26259579; PMCID: PMC4535193.
  13. Kwong RY, Heydari B, Abbasi S, Steel K, Al-Mallah M, Wu H, Falk RH. Characterization of Cardiac Amyloidosis by Atrial Late Gadolinium Enhancement Using Contrast-Enhanced Cardiac Magnetic Resonance Imaging and Correlation With Left Atrial Conduit and Contractile Function. Am J Cardiol. 2015 Aug 15; 116(4):622-9. PMID: 26076990; PMCID: PMC4769620.
  14. Guan J, Mishra S, Qiu Y, Shi J, Trudeau K, Las G, Liesa M, Shirihai OS, Connors LH, Seldin DC, Falk RH, MacRae CA, Liao R. Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain-mediated cardiotoxicity. EMBO Mol Med. 2015 May; 7(5):688. PMID: 25940533; PMCID: PMC4492824.
  15. Quarta CC, Falk RH, Solomon SD. V122I transthyretin variant in elderly black Americans. N Engl J Med. 2015 Apr 30; 372(18):1769. PMID: 25923562.
    View in: PubMed
  16. Maurer MS, Grogan DR, Judge DP, Mundayat R, Packman J, Lombardo I, Quyyumi AA, Aarts J, Falk RH. Tafamidis in transthyretin amyloid cardiomyopathy: effects on transthyretin stabilization and clinical outcomes. Circ Heart Fail. 2015 May; 8(3):519-26. PMID: 25872787.
    View in: PubMed
  17. Falk RH, Quarta CC. Echocardiography in cardiac amyloidosis. Heart Fail Rev. 2015 Mar; 20(2):125-31. PMID: 25597027.
    View in: PubMed
  18. Quarta CC, Buxbaum JN, Shah AM, Falk RH, Claggett B, Kitzman DW, Mosley TH, Butler KR, Boerwinkle E, Solomon SD. The amyloidogenic V122I transthyretin variant in elderly black Americans. N Engl J Med. 2015 Jan 01; 372(1):21-9. PMID: 25551524; PMCID: PMC4382209.
  19. Guan J, Mishra S, Qiu Y, Shi J, Trudeau K, Las G, Liesa M, Shirihai OS, Connors LH, Seldin DC, Falk RH, MacRae CA, Liao R. Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain-mediated cardiotoxicity. EMBO Mol Med. 2014 Nov; 6(11):1493-507. PMID: 25319546; PMCID: PMC4237473.
  20. Falk RH. "Bendopnea" or "kamptopnea?": Some thoughts on terminology and mechanisms. JACC Heart Fail. 2014 Aug; 2(4):425. PMID: 25103981.
    View in: PubMed
  21. Dorbala S, Vangala D, Bruyere J, Quarta C, Kruger J, Padera R, Foster C, Hanley M, Di Carli MF, Falk R. Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis. JACC Heart Fail. 2014 Aug; 2(4):358-67. PMID: 25023822; PMCID: PMC4127145.
  22. Dorbala S, Vangala D, Semer J, Strader C, Bruyere JR, Di Carli MF, Moore SC, Falk RH. Imaging cardiac amyloidosis: a pilot study using ¹8F-florbetapir positron emission tomography. Eur J Nucl Med Mol Imaging. 2014 Sep; 41(9):1652-62. PMID: 24841414.
    View in: PubMed
  23. Falk RH, Quarta CC, Dorbala S. How to image cardiac amyloidosis. Circ Cardiovasc Imaging. 2014 May; 7(3):552-62. PMID: 24847009; PMCID: PMC4118308.
  24. Quarta CC, Solomon SD, Uraizee I, Kruger J, Longhi S, Ferlito M, Gagliardi C, Milandri A, Rapezzi C, Falk RH. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis. Circulation. 2014 May 06; 129(18):1840-9. PMID: 24563469.
    View in: PubMed
  25. Falk RH. AL amyloidosis or multiple myeloma? An important distinction. Br J Haematol. 2014 Mar; 164(5):748-9. PMID: 24261595.
    View in: PubMed
  26. Guan J, Mishra S, Shi J, Plovie E, Qiu Y, Cao X, Gianni D, Jiang B, Del Monte F, Connors LH, Seldin DC, Lavatelli F, Rognoni P, Palladini G, Merlini G, Falk RH, Semigran MJ, Dec GW, Macrae CA, Liao R. Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicity. Basic Res Cardiol. 2013 Sep; 108(5):378. PMID: 23982491; PMCID: PMC3914405.
  27. Mishra S, Guan J, Plovie E, Seldin DC, Connors LH, Merlini G, Falk RH, MacRae CA, Liao R. Human amyloidogenic light chain proteins result in cardiac dysfunction, cell death, and early mortality in zebrafish. Am J Physiol Heart Circ Physiol. 2013 Jul 01; 305(1):H95-103. PMID: 23624626; PMCID: PMC3727100.
  28. Quarta CC, Falk RH. A transthyretin variant, Asp18Asn, associated with amyloid cardiomyopathy: a new African-American variant? Amyloid. 2012 Dec; 19(4):204-7. PMID: 23126592.
    View in: PubMed
  29. Quarta CC, Kruger JL, Falk RH. Cardiac amyloidosis. Circulation. 2012 Sep 18; 126(12):e178-82. PMID: 22988049.
    View in: PubMed
  30. Mongeon FP, Jerosch-Herold M, Coelho-Filho OR, Blankstein R, Falk RH, Kwong RY. Quantification of extracellular matrix expansion by CMR in infiltrative heart disease. JACC Cardiovasc Imaging. 2012 Sep; 5(9):897-907. PMID: 22974802; PMCID: PMC3954504.
  31. Quarta CC, Falk RH. Longitudinal strain imaging in light-chain cardiac amyloidosis: can it help to refine the approach to treatment? J Am Coll Cardiol. 2012 Sep 18; 60(12):1077-8. PMID: 22883633.
    View in: PubMed
  32. Ruberg FL, Maurer MS, Judge DP, Zeldenrust S, Skinner M, Kim AY, Falk RH, Cheung KN, Patel AR, Pano A, Packman J, Grogan DR. Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS). Am Heart J. 2012 Aug; 164(2):222-228.e1. PMID: 22877808.
    View in: PubMed
  33. Falk RH. Senile systemic amyloidosis: are regional differences real or do they reflect different diagnostic suspicion and use of techniques? Amyloid. 2012 Jun; 19 Suppl 1:68-70. PMID: 22620969.
    View in: PubMed
  34. Philippakis AA, Falk RH. Cardiac amyloidosis mimicking hypertrophic cardiomyopathy with obstruction: treatment with disopyramide. Circulation. 2012 Apr 10; 125(14):1821-4. PMID: 22492950.
    View in: PubMed
  35. Comenzo RL, Reece D, Palladini G, Seldin D, Sanchorawala V, Landau H, Falk R, Wells K, Solomon A, Wechalekar A, Zonder J, Dispenzieri A, Gertz M, Streicher H, Skinner M, Kyle RA, Merlini G. Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis. Leukemia. 2012 Nov; 26(11):2317-25. PMID: 22475872.
    View in: PubMed
  36. Falk RH. Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med. 2012 Mar 22; 366(12):1159-60; author reply 1161. PMID: 22435379.
    View in: PubMed
  37. Girouard SD, Falk RH, Rennke HG, Merola JF. Hidradenitis suppurativa resulting in systemic amyloid A amyloidosis: a case report and review of the literature. Dermatol Online J. 2012 Jan 15; 18(1):2. PMID: 22301039.
    View in: PubMed
  38. Falk RH. Letter by Falk regarding article, "An unusual heart failure: cardiac amyloidosis due to light chain myeloma". Circulation. 2011 Nov 15; 124(20):e534; author reply e535. PMID: 22083153.
    View in: PubMed
  39. Guan J, Mishra S, Falk RH, Liao R. Current perspectives on cardiac amyloidosis. Am J Physiol Heart Circ Physiol. 2012 Feb 01; 302(3):H544-52. PMID: 22058156; PMCID: PMC3353775.
  40. Falk RH. Cardiac amyloidosis: a treatable disease, often overlooked. Circulation. 2011 Aug 30; 124(9):1079-85. PMID: 21875922.
    View in: PubMed
  41. Rajab TK, Shekar P, Falk RH. Myxoma, dyspnoea, tinnitus, scoliosis, and alopecia. Lancet. 2011 Apr 16; 377(9774):1378. PMID: 21497702.
    View in: PubMed
  42. Falk RH, Dorbala S. Pursuing an underdiagnosed disease: a simple imaging test for increasing suspicion of cardiac amyloidosis. Eur J Nucl Med Mol Imaging. 2011 Mar; 38(3):467-9. PMID: 21267559.
    View in: PubMed
  43. Falk RH. Pulmonary venous isolation for atrial fibrillation in severe systolic heart failure: more questions than answers? Heart. 2011 May; 97(9):687-8. PMID: 21282135.
    View in: PubMed
  44. Dubrey SW, Hawkins PN, Falk RH. Amyloid diseases of the heart: assessment, diagnosis, and referral. Heart. 2011 Jan; 97(1):75-84. PMID: 21148582.
    View in: PubMed
  45. Miller AL, Falk RH, Levy BD, Loscalzo J. Clinical problem-solving. A heavy heart. N Engl J Med. 2010 Oct 07; 363(15):1464-9. PMID: 20925549.
    View in: PubMed
  46. Koyama J, Falk RH. Prognostic significance of strain Doppler imaging in light-chain amyloidosis. JACC Cardiovasc Imaging. 2010 Apr; 3(4):333-42. PMID: 20394893.
    View in: PubMed
  47. Shi J, Guan J, Jiang B, Brenner DA, Del Monte F, Ward JE, Connors LH, Sawyer DB, Semigran MJ, Macgillivray TE, Seldin DC, Falk R, Liao R. Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38alpha MAPK pathway. Proc Natl Acad Sci U S A. 2010 Mar 02; 107(9):4188-93. PMID: 20150510; PMCID: PMC2840082.
  48. Dubrey SW, Falk RH. Amyloid heart disease. Br J Hosp Med (Lond). 2010 Feb; 71(2):76-82. PMID: 20220694.
    View in: PubMed
  49. Dubrey SW, Falk RH. Diagnosis and management of cardiac sarcoidosis. Prog Cardiovasc Dis. 2010 Jan-Feb; 52(4):336-46. PMID: 20109603.
    View in: PubMed
  50. Falk RH, Dubrey SW. Amyloid heart disease. Prog Cardiovasc Dis. 2010 Jan-Feb; 52(4):347-61. PMID: 20109604.
    View in: PubMed
  51. Falk RH, Elkayam U. Cardiomyopathy: the importance of recognizing the uncommon diagnosis. Prog Cardiovasc Dis. 2010 Jan-Feb; 52(4):262-3. PMID: 20109596.
    View in: PubMed
  52. Falk RH. Severe hypercalcaemia mimicking acute myocardial infarction. Clin Med (Lond). 2009 Oct; 9(5):503-4; author reply 504. PMID: 19891057.
    View in: PubMed
  53. Connors LH, Prokaeva T, Lim A, Théberge R, Falk RH, Doros G, Berg A, Costello CE, O'Hara C, Seldin DC, Skinner M. Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis. Am Heart J. 2009 Oct; 158(4):607-14. PMID: 19781421.
    View in: PubMed
  54. Falk RH, Camm AJ. Rethinking the reasons to treat atrial fibrillation? The role of dronedarone in reducing cardiovascular hospitalizations. Eur Heart J. 2009 Oct; 30(20):2438-40. PMID: 19744955.
    View in: PubMed
  55. Falk RH. Driving and ventricular arrhythmia: a historical perspective. J Am Coll Cardiol. 2008 Jul 22; 52(4):316; author reply 317. PMID: 18634990.
    View in: PubMed
  56. Falk RH. Ethnic disparity in intracranial hemorrhage among anticoagulated patients with atrial fibrillation: an answer in search of a question? J Am Coll Cardiol. 2007 Jul 24; 50(4):316-8. PMID: 17659198.
    View in: PubMed
  57. Falk RH. Atrial fibrillation or sinus rhythm? Controversy and contradiction in quality of life outcomes. J Am Coll Cardiol. 2006 Aug 15; 48(4):731-3. PMID: 16904541.
    View in: PubMed
  58. Wiebert P, Sanchez-Crespo A, Seitz J, Falk R, Philipson K, Kreyling WG, Möller W, Sommerer K, Larsson S, Svartengren M. Negligible clearance of ultrafine particles retained in healthy and affected human lungs. Eur Respir J. 2006 Aug; 28(2):286-90. PMID: 16641121.
    View in: PubMed
  59. Akar H, Seldin DC, Magnani B, O'Hara C, Berk JL, Schoonmaker C, Cabral H, Dember LM, Sanchorawala V, Connors LH, Falk RH, Skinner M. Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis. Amyloid. 2005 Dec; 12(4):210-5. PMID: 16399645.
    View in: PubMed
  60. Nordlinger M, Magnani B, Skinner M, Falk RH. Is elevated plasma B-natriuretic peptide in amyloidosis simply a function of the presence of heart failure? Am J Cardiol. 2005 Oct 01; 96(7):982-4. PMID: 16188528.
    View in: PubMed
  61. Falk RH. Diagnosis and management of the cardiac amyloidoses. Circulation. 2005 Sep 27; 112(13):2047-60. PMID: 16186440.
    View in: PubMed
  62. Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN, Merlini G, Moreau P, Ronco P, Sanchorawala V, Sezer O, Solomon A, Grateau G. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol. 2005 Aug; 79(4):319-28. PMID: 16044444.
    View in: PubMed
  63. Ng B, Connors LH, Davidoff R, Skinner M, Falk RH. Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis. Arch Intern Med. 2005 Jun 27; 165(12):1425-9. PMID: 15983293.
    View in: PubMed
  64. Falk RH. Is rate control or rhythm control preferable in patients with atrial fibrillation? Rate control is preferable to rhythm control in the majority of patients with atrial fibrillation. Circulation. 2005 Jun 14; 111(23):3141-50; discussion 3157. PMID: 15956148.
    View in: PubMed
  65. Ogiwara F, Koyama J, Ikeda S, Kinoshita O, Falk RH. Comparison of the strain Doppler echocardiographic features of familial amyloid polyneuropathy (FAP) and light-chain amyloidosis. Am J Cardiol. 2005 Feb 15; 95(4):538-40. PMID: 15695150.
    View in: PubMed
  66. Kwong RY, Falk RH. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2005 Jan 18; 111(2):122-4. PMID: 15657385.
    View in: PubMed
  67. Falk RH. Reconsidering combined antiplatelet and anticoagulant therapy in atrial fibrillation. J Am Coll Cardiol. 2004 Oct 19; 44(8):1567-9. PMID: 15489086.
    View in: PubMed
  68. Ezekowitz MD, Falk RH. The increasing need for anticoagulant therapy to prevent stroke in patients with atrial fibrillation. Mayo Clin Proc. 2004 Jul; 79(7):904-13. PMID: 15244388.
    View in: PubMed
  69. Cleland JG, Findlay I, Jafri S, Sutton G, Falk R, Bulpitt C, Prentice C, Ford I, Trainer A, Poole-Wilson PA. The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. Am Heart J. 2004 Jul; 148(1):157-64. PMID: 15215806.
    View in: PubMed
  70. Seldin DC, Anderson JJ, Sanchorawala V, Malek K, Wright DG, Quillen K, Finn KT, Berk JL, Dember LM, Falk RH, Skinner M. Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation. Blood. 2004 Sep 15; 104(6):1888-93. PMID: 15155460.
    View in: PubMed
  71. Sanchorawala V, Wright DG, Seldin DC, Falk RH, Finn KT, Dember LM, Berk JL, Quillen K, Anderson JJ, Comenzo RL, Skinner M. High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial. Bone Marrow Transplant. 2004 Feb; 33(4):381-8. PMID: 14676787.
    View in: PubMed
  72. Skinner M, Sanchorawala V, Seldin DC, Dember LM, Falk RH, Berk JL, Anderson JJ, O'Hara C, Finn KT, Libbey CA, Wiesman J, Quillen K, Swan N, Wright DG. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Ann Intern Med. 2004 Jan 20; 140(2):85-93. PMID: 14734330.
    View in: PubMed
  73. Koyama J, Davidoff R, Falk RH. Longitudinal myocardial velocity gradient derived from pulsed Doppler tissue imaging in AL amyloidosis: a sensitive indicator of systolic and diastolic dysfunction. J Am Soc Echocardiogr. 2004 Jan; 17(1):36-44. PMID: 14712185.
    View in: PubMed
  74. Berk JL, Keane J, Seldin DC, Sanchorawala V, Koyama J, Dember LM, Falk RH. Persistent pleural effusions in primary systemic amyloidosis: etiology and prognosis. Chest. 2003 Sep; 124(3):969-77. PMID: 12970025.
    View in: PubMed
  75. Singh SN, Singh BN, Reda DJ, Fye CL, Ezekowitz MD, Fletcher RD, Sharma SC, Atwood JE, Jacobson AK, Lewis HD, Antman EM, Falk RH, Lopez B, Tang XC. Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with atrial fibrillation (Sotalol-Amiodarone Fibrillation Efficacy Trial [Safe-T]). Am J Cardiol. 2003 Aug 15; 92(4):468-72. PMID: 12914883.
    View in: PubMed
  76. O'Hara CJ, Falk RH. The diagnosis and typing of cardiac amyloidosis. Amyloid. 2003 Jun; 10(2):127-9. PMID: 12964421.
    View in: PubMed
  77. Berghoff M, Kathpal M, Khan F, Skinner M, Falk R, Freeman R. Endothelial dysfunction precedes C-fiber abnormalities in primary (AL) amyloidosis. Ann Neurol. 2003 Jun; 53(6):725-30. PMID: 12783418.
    View in: PubMed
  78. Koyama J, Ray-Sequin PA, Falk RH. Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation. 2003 May 20; 107(19):2446-52. PMID: 12743000.
    View in: PubMed
  79. Falk RH. Adenosine-induced ventricular flutter? Am J Emerg Med. 2003 May; 21(3):249. PMID: 12892107.
    View in: PubMed
  80. Seldin DC, Choufani EB, Dember LM, Wiesman JF, Berk JL, Falk RH, O'Hara C, Fennessey S, Finn KT, Wright DG, Skinner M, Sanchorawala V. Tolerability and efficacy of thalidomide for the treatment of patients with light chain-associated (AL) amyloidosis. Clin Lymphoma. 2003 Mar; 3(4):241-6. PMID: 12672274.
    View in: PubMed
  81. Falk RH. Management of atrial fibrillation--radical reform or modest modification? N Engl J Med. 2002 Dec 05; 347(23):1883-4. PMID: 12466514.
    View in: PubMed
  82. Falk RH. Ventricular rate control in the elderly: is digoxin enough? Am J Geriatr Cardiol. 2002 Nov-Dec; 11(6):353-6. PMID: 12417840.
    View in: PubMed
  83. Koyama J, Ray-Sequin PA, Falk RH. Prognostic significance of ultrasound myocardial tissue characterization in patients with cardiac amyloidosis. Circulation. 2002 Jul 30; 106(5):556-61. PMID: 12147536.
    View in: PubMed
  84. Sanchorawala V, Wright DG, Seldin DC, Falk RH, Berk JL, Dember LM, Finn KT, Skinner M. Low-dose continuous oral melphalan for the treatment of primary systemic (AL) amyloidosis. Br J Haematol. 2002 Jun; 117(4):886-9. PMID: 12060126.
    View in: PubMed
  85. Lim A, Prokaeva T, Connor LH, Falk RH, Skinner M, Costello CE. Identification of a novel transthyretin Thr59Lys/Arg104His. A case of compound heterozygosity in a Chinese patient diagnosed with familial transthyretin amyloidosis. Amyloid. 2002 Jun; 9(2):134-40. PMID: 12440486.
    View in: PubMed
  86. Koyama J, Ray-Sequin PA, Davidoff R, Falk RH. Usefulness of pulsed tissue Doppler imaging for evaluating systolic and diastolic left ventricular function in patients with AL (primary) amyloidosis. Am J Cardiol. 2002 May 01; 89(9):1067-71. PMID: 11988197.
    View in: PubMed
  87. Falk RH. The neglected entity of familial cardiac amyloidosis in African Americans. Ethn Dis. 2002; 12(1):141-3. PMID: 11913602.
    View in: PubMed
  88. Khan MF, Falk RH. Amyloidosis. Postgrad Med J. 2001 Nov; 77(913):686-93. PMID: 11677276; PMCID: PMC1742163.
  89. Liao R, Jain M, Teller P, Connors LH, Ngoy S, Skinner M, Falk RH, Apstein CS. Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts. Circulation. 2001 Oct 02; 104(14):1594-7. PMID: 11581134.
    View in: PubMed
  90. Sanchorawala V, Wright DG, Seldin DC, Dember LM, Finn K, Falk RH, Berk J, Quillen K, Skinner M. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis. Bone Marrow Transplant. 2001 Oct; 28(7):637-42. PMID: 11704785.
    View in: PubMed
  91. Dember LM, Sanchorawala V, Seldin DC, Wright DG, LaValley M, Berk JL, Falk RH, Skinner M. Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on al amyloidosis-associated renal disease. Ann Intern Med. 2001 May 01; 134(9 Pt 1):746-53. PMID: 11329232.
    View in: PubMed
  92. Falk RH. Atrial fibrillation. N Engl J Med. 2001 Apr 05; 344(14):1067-78. PMID: 11287978.
    View in: PubMed
  93. Falk RH. The cardiovascular response to sexual activity: do we know enough? Clin Cardiol. 2001 Apr; 24(4):271-5. PMID: 11303692.
    View in: PubMed
  94. Matsui K, Beasley MB, Nelson WK, Barnes PM, Bechtle J, Falk R, Ferrans VJ, Moss J, Travis WD. Prognostic significance of pulmonary lymphangioleiomyomatosis histologic score. Am J Surg Pathol. 2001 Apr; 25(4):479-84. PMID: 11257622.
    View in: PubMed
  95. Falk RH, Decara JM. Dofetilide: a new pure class III antiarrhythmic agent. Am Heart J. 2000 Nov; 140(5):697-706. PMID: 11054613.
    View in: PubMed
  96. DeCara JM, Pollak A, Dubrey S, Falk RH. Positive atrial inotropic effect of dofetilide after cardioversion of atrial fibrillation or flutter. Am J Cardiol. 2000 Sep 15; 86(6):685-8, A8. PMID: 10980226.
    View in: PubMed
  97. Murphy L, Falk RH. Left atrial kinetic energy in AL amyloidosis: can it detect early dysfunction? Am J Cardiol. 2000 Jul 15; 86(2):244-6. PMID: 10913497.
    View in: PubMed
  98. Khan MF, Falk RH. S1 in Wolff-Parkinson-White syndrome. Am J Cardiol. 2000 Jun 15; 85(12):1510. PMID: 10939982.
    View in: PubMed
  99. Falk RH, Skinner M. The systemic amyloidoses: an overview. Adv Intern Med. 2000; 45:107-37. PMID: 10635047.
    View in: PubMed
  100. Connors LH, Théberge R, Skare J, Costello CE, Falk RH, Skinner M. A new transthyretin variant (Ser23Asn) associated with familial amyloidosis in a Portuguese patient. Amyloid. 1999 Jun; 6(2):114-8. PMID: 10439117.
    View in: PubMed
  101. Théberge R, Connors L, Skare J, Skinner M, Falk RH, Costello CE. A new amyloidogenic transthyretin variant (Val122Ala) found in a compound heterozygous patient. Amyloid. 1999 Mar; 6(1):54-8. PMID: 10211412.
    View in: PubMed
  102. Comenzo RL, Sanchorawala V, Fisher C, Akpek G, Farhat M, Cerda S, Berk JL, Dember LM, Falk R, Finn K, Skinner M, Vosburgh E. Intermediate-dose intravenous melphalan and blood stem cells mobilized with sequential GM+G-CSF or G-CSF alone to treat AL (amyloid light chain) amyloidosis. Br J Haematol. 1999 Mar; 104(3):553-9. PMID: 10086794.
    View in: PubMed
  103. Falk RH. Etiology and complications of atrial fibrillation: insights from pathology studies. Am J Cardiol. 1998 Oct 16; 82(8A):10N-17N. PMID: 9809896.
    View in: PubMed
  104. Eckman MH, Falk RH, Pauker SG. Cost-effectiveness of therapies for patients with nonvalvular atrial fibrillation. Arch Intern Med. 1998 Aug 10-24; 158(15):1669-77. PMID: 9701102.
    View in: PubMed
  105. Comenzo RL, Vosburgh E, Falk RH, Sanchorawala V, Reisinger J, Dubrey S, Dember LM, Berk JL, Akpek G, LaValley M, O'hara C, Arkin CF, Wright DG, Skinner M. Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients. Blood. 1998 May 15; 91(10):3662-70. PMID: 9573002.
    View in: PubMed
  106. Falk RH, Decara J, Abascal V. Is pharmacologic cardioversion of atrial fibrillation really preferable to electrical cardioversion? J Am Coll Cardiol. 1998 May; 31(6):1446-7. PMID: 9581752.
    View in: PubMed
  107. Pomfret EA, Lewis WD, Jenkins RL, Bergethon P, Dubrey SW, Reisinger J, Falk RH, Skinner M. Effect of orthotopic liver transplantation on the progression of familial amyloidotic polyneuropathy. Transplantation. 1998 Apr 15; 65(7):918-25. PMID: 9565095.
    View in: PubMed
  108. Dubrey SW, Cha K, Anderson J, Chamarthi B, Reisinger J, Skinner M, Falk RH. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. QJM. 1998 Feb; 91(2):141-57. PMID: 9578896.
    View in: PubMed
  109. DeCara JM, Croze S, Falk RH. Generic warfarin: a cost-effective alternative to brand-name drug or a clinical wild card? Chest. 1998 Feb; 113(2):261-3. PMID: 9498932.
    View in: PubMed
  110. Dubrey SW, Bilazarian S, LaValley M, Reisinger J, Skinner M, Falk RH. Signal-averaged electrocardiography in patients with AL (primary) amyloidosis. Am Heart J. 1997 Dec; 134(6):994-1001. PMID: 9424057.
    View in: PubMed
  111. Chamarthi B, Dubrey SW, Cha K, Skinner M, Falk RH. Features and prognosis of exertional syncope in light-chain associated AL cardiac amyloidosis. Am J Cardiol. 1997 Nov 01; 80(9):1242-5. PMID: 9359565.
    View in: PubMed
  112. Reisinger J, Dubrey SW, Lavalley M, Skinner M, Falk RH. Electrophysiologic abnormalities in AL (primary) amyloidosis with cardiac involvement. J Am Coll Cardiol. 1997 Oct; 30(4):1046-51. PMID: 9316537.
    View in: PubMed
  113. Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med. 1997 Sep 25; 337(13):898-909. PMID: 9302305.
    View in: PubMed
  114. Patel AR, Dubrey SW, Mendes LA, Skinner M, Cupples A, Falk RH, Davidoff R. Right ventricular dilation in primary amyloidosis: an independent predictor of survival. Am J Cardiol. 1997 Aug 15; 80(4):486-92. PMID: 9285663.
    View in: PubMed
  115. Dubrey SW, Davidoff R, Skinner M, Bergethon P, Lewis D, Falk RH. Progression of ventricular wall thickening after liver transplantation for familial amyloidosis. Transplantation. 1997 Jul 15; 64(1):74-80. PMID: 9233704.
    View in: PubMed
  116. Dubrey SW, Cha K, Skinner M, LaValley M, Falk RH. Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes. Heart. 1997 Jul; 78(1):74-82. PMID: 9290406; PMCID: PMC484868.
  117. Reisinger J, Dubrey SW, Falk RH. Restrictive cardiomyopathy. N Engl J Med. 1997 Jun 26; 336(26):1917; author reply 1917-8. PMID: 9198760.
    View in: PubMed
  118. Falk RH, Pollak A, Singh SN, Friedrich T. Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators. J Am Coll Cardiol. 1997 Feb; 29(2):385-90. PMID: 9014993.
    View in: PubMed
  119. Reisinger J, Falk RH. Clinical value of a new Doppler index in cardiac amyloidosis. J Am Coll Cardiol. 1997 Feb; 29(2):471-2. PMID: 9015010.
    View in: PubMed
  120. Dubrey SW, Falk RH. Optimal number of beats for the Doppler measurement of cardiac output in atrial fibrillation. J Am Soc Echocardiogr. 1997 Jan-Feb; 10(1):67-71. PMID: 9046495.
    View in: PubMed
  121. Falk RH. Pharmacologic control of heart rate in atrial fibrillation. Cardiol Clin. 1996 Nov; 14(4):521-36. PMID: 8950054.
    View in: PubMed
  122. Comenzo RL, Vosburgh E, Simms RW, Bergethon P, Sarnacki D, Finn K, Dubrey S, Faller DV, Wright DG, Falk RH, Skinner M. Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patients. Blood. 1996 Oct 01; 88(7):2801-6. PMID: 8839879.
    View in: PubMed
  123. Dubrey S, Mendes L, Skinner M, Falk RH. Resolution of heart failure in patients with AL amyloidosis. Ann Intern Med. 1996 Sep 15; 125(6):481-4. PMID: 8779461.
    View in: PubMed
  124. Dubrey S, Falk RH. QT interval in cardiac amyloidosis. Clin Cardiol. 1996 May; 19(5):A22, 442. PMID: 8723590.
    View in: PubMed
  125. Cleland JG, Cowburn PJ, Falk RH. Should all patients with atrial fibrillation receive warfarin? Evidence from randomized clinical trials. Eur Heart J. 1996 May; 17(5):674-81. PMID: 8737097.
    View in: PubMed
  126. Cha K, Falk RH. Images in clinical medicine. Pulsus alternans. N Engl J Med. 1996 Mar 28; 334(13):834. PMID: 8596550.
    View in: PubMed
  127. Skinner M, Anderson J, Simms R, Falk R, Wang M, Libbey C, Jones LA, Cohen AS. Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only. Am J Med. 1996 Mar; 100(3):290-8. PMID: 8629674.
    View in: PubMed
  128. Dubrey SW, Cha K, Simms RW, Skinner M, Falk RH. Electrocardiography and Doppler echocardiography in secondary (AA) amyloidosis. Am J Cardiol. 1996 Feb 01; 77(4):313-5. PMID: 8607418.
    View in: PubMed
  129. Dubrey S, Falk R. Thyrotoxicosis and dilated cardiomyopathy. Am Heart J. 1995 Dec; 130(6):1314-5. PMID: 7484799.
    View in: PubMed
  130. Falk RH. A posterior mediastinal mass diagnosed by echocardiogram. Chest. 1995 Nov; 108(5):1447-8. PMID: 7587456.
    View in: PubMed
  131. Dubrey S, Pollak A, Skinner M, Falk RH. Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation. Br Heart J. 1995 Nov; 74(5):541-4. PMID: 8562243; PMCID: PMC484078.
  132. Dubrey S, Simms RW, Skinner M, Falk RH. Recurrence of primary (AL) amyloidosis in a transplanted heart with four-year survival. Am J Cardiol. 1995 Oct 01; 76(10):739-41. PMID: 7572642.
    View in: PubMed
  133. Cleland JG, Bulpitt CJ, Falk RH, Findlay IN, Oakley CM, Murray G, Poole-Wilson PA, Prentice CR, Sutton GC. Is aspirin safe for patients with heart failure? Br Heart J. 1995 Sep; 74(3):215-9. PMID: 7547012; PMCID: PMC484008.
  134. Falk RH. Images in clinical medicine. The "thumb sign" in Marfan's syndrome. N Engl J Med. 1995 Aug 17; 333(7):430. PMID: 7616992.
    View in: PubMed
  135. Dubrey S, Falk RH. Palpitations in idiopathic dilated cardiomyopathy. Am J Cardiol. 1995 May 15; 75(15):1081. PMID: 7747695.
    View in: PubMed
  136. Sung RJ, Tan HL, Karagounis L, Hanyok JJ, Falk R, Platia E, Das G, Hardy SA. Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group. Am Heart J. 1995 Apr; 129(4):739-48. PMID: 7900626.
    View in: PubMed
  137. Falk RH. A response to the letter on electrical cardioversion resulting in death from synchronization failure. Am J Cardiol. 1995 Mar 01; 75(7):551. PMID: 7864016.
    View in: PubMed
  138. Pollak A, Falk RH. Aggravation of postcardioversion atrial dysfunction by sotalol. J Am Coll Cardiol. 1995 Mar 01; 25(3):665-71. PMID: 7860911.
    View in: PubMed
  139. Falk RH, Fogel RI. Flecainide. J Cardiovasc Electrophysiol. 1994 Nov; 5(11):964-81. PMID: 7889236.
    View in: PubMed
  140. Falk RH, Pollak A. Signal-averaged P wave duration and atrial fibrillation. J Am Coll Cardiol. 1994 Feb; 23(2):549-50. PMID: 8294715.
    View in: PubMed
  141. Skinner M, Lewis WD, Jones LA, Kasirsky J, Kane K, Ju ST, Jenkins R, Falk RH, Simms RW, Cohen AS. Liver transplantation as a treatment for familial amyloidotic polyneuropathy. Ann Intern Med. 1994 Jan 15; 120(2):133-4. PMID: 8256972.
    View in: PubMed
  142. Falk RH. Current management of atrial fibrillation. Curr Opin Cardiol. 1994 Jan; 9(1):30-9. PMID: 8199369.
    View in: PubMed
  143. Falk RH, Battinelli NJ. External cardiac pacing using low impedance electrodes suitable for defibrillation: a comparative blinded study. J Am Coll Cardiol. 1993 Nov 01; 22(5):1354-8. PMID: 8227791.
    View in: PubMed
  144. Pollak A, Falk RH. Left ventricular systolic dysfunction precipitated by verapamil in cardiac amyloidosis. Chest. 1993 Aug; 104(2):618-20. PMID: 8339658.
    View in: PubMed
  145. Pollak A, Falk RH. Pacemaker therapy in patients with atrial fibrillation. Am Heart J. 1993 Mar; 125(3):824-30. PMID: 8094937.
    View in: PubMed
  146. Falk RH. Proarrhythmia in patients treated for atrial fibrillation or flutter. Ann Intern Med. 1992 Jul 15; 117(2):141-50. PMID: 1605429.
    View in: PubMed
  147. Pollak A, Falk RH. New criteria for diagnosis of regular, wide-complex tachycardias. Circulation. 1992 May; 85(5):1955-6. PMID: 1572055.
    View in: PubMed
  148. Leavitt JA, Turner AK, Battinelli NJ, Coats MH, Falk RH. Reproducibility of the catecholamine response to serial exercise testing in normals. Am J Med Sci. 1992 Mar; 303(3):160-4. PMID: 1595777.
    View in: PubMed
  149. Falk RH, Foster E, Coats MH. Ventricular thrombi and thromboembolism in dilated cardiomyopathy: a prospective follow-up study. Am Heart J. 1992 Jan; 123(1):136-42. PMID: 1729816.
    View in: PubMed
  150. Pollak A, Falk RH. Predictive value of P wave-triggered signal averaging of the electrocardiogram. Circulation. 1991 Dec; 84(6):2606-7. PMID: 1959213.
    View in: PubMed
  151. Falk RH. Digoxin: mythology or evidence? Ann Intern Med. 1991 Aug 15; 115(4):329. PMID: 1854123.
    View in: PubMed
  152. Leavitt JI, Coats MH, Falk RH. Effects of exercise on transmitral gradient and pulmonary artery pressure in patients with mitral stenosis or a prosthetic mitral valve: a Doppler echocardiographic study. J Am Coll Cardiol. 1991 Jun; 17(7):1520-6. PMID: 2033184.
    View in: PubMed
  153. Falk RH. PFO or UFO? The role of a patent foramen ovale in cryptogenic stroke. Am Heart J. 1991 Apr; 121(4 Pt 1):1264-6. PMID: 2008854.
    View in: PubMed
  154. Falk RH, Leavitt JI. Digoxin for atrial fibrillation: a drug whose time has gone? Ann Intern Med. 1991 Apr 01; 114(7):573-5. PMID: 2001090.
    View in: PubMed
  155. Falk RH. Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin. Br Heart J. 1990 Dec; 64(6):409. PMID: 2271354; PMCID: PMC1224823.
  156. Knowlton AA, Falk RH. Paradoxical increase in heart rate before conversion to sinus rhythm in patients with recent-onset atrial fibrillation. Am J Cardiol. 1990 Apr 01; 65(13):930-2. PMID: 2321547.
    View in: PubMed
  157. Falk RH. Impact of prospective peer review on pacemaker implantation rates in Massachusetts. J Am Coll Cardiol. 1990 Apr; 15(5):1087-92. PMID: 2312963.
    View in: PubMed
  158. Falk RH. A plea for a clinical trial of anticoagulation in dilated cardiomyopathy. Am J Cardiol. 1990 Apr 01; 65(13):914-5. PMID: 2181847.
    View in: PubMed
  159. Falk RH. Flecainide-induced ventricular tachycardia and fibrillation in patients treated for atrial fibrillation. Ann Intern Med. 1989 Jul 15; 111(2):107-11. PMID: 2500880.
    View in: PubMed
  160. Falk RH, Knowlton AA, Battinelli NJ. The effect of propranolol and verapamil on external pacing threshold: a placebo-controlled study. Pacing Clin Electrophysiol. 1988 Oct; 11(10):1439-43. PMID: 2462221.
    View in: PubMed
  161. Falk RH, Knowlton AA, Manaker S. Verapamil-induced atrial fibrillation. N Engl J Med. 1988 Mar 10; 318(10):640-1. PMID: 3344011.
    View in: PubMed
  162. Falk RH. A nameless obituary. Reflections on the depersonalization of the elderly. Am J Med. 1987 Dec; 83(6):1134. PMID: 3503580.
    View in: PubMed
  163. Falk RH, Werner M. Transesophageal atrial pacing using a pill electrode for the termination of atrial flutter. Chest. 1987 Jul; 92(1):110-4. PMID: 3595221.
    View in: PubMed
  164. Falk RH, Knowlton AA. Atypical ventricular tachycardia or motion artifact? Am J Cardiol. 1987 Apr 01; 59(8):924. PMID: 3825957.
    View in: PubMed
  165. Falk RH, Knowlton AA, Bernard SA, Gotlieb NE, Battinelli NJ. Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial. Ann Intern Med. 1987 Apr; 106(4):503-6. PMID: 3548521.
    View in: PubMed
  166. Falk RH, Plehn JF, Deering T, Schick EC, Boinay P, Rubinow A, Skinner M, Cohen AS. Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis. Am J Cardiol. 1987 Feb 15; 59(5):418-22. PMID: 2949593.
    View in: PubMed
  167. Falk RH. Pseudoparadoxic effect of atropine and carotid sinus massage on atrioventricular conduction in acute myocardial infarction. Chest. 1986 Oct; 90(4):601-3. PMID: 3757570.
    View in: PubMed
  168. Knowlton AA, Falk RH. External cardiac pacing during in-hospital cardiac arrest. Am J Cardiol. 1986 Jun 01; 57(15):1295-8. PMID: 3717028.
    View in: PubMed
  169. Gertz MA, Falk RH, Skinner M, Cohen AS, Kyle RA. Worsening of congestive heart failure in amyloid heart disease treated by calcium channel-blocking agents. Am J Cardiol. 1985 Jun 01; 55(13 Pt 1):1645. PMID: 4003314.
    View in: PubMed
  170. Gertz MA, Skinner M, Connors LH, Falk RH, Cohen AS, Kyle RA. Selective binding of nifedipine to amyloid fibrils. Am J Cardiol. 1985 Jun 01; 55(13 Pt 1):1646. PMID: 4003315.
    View in: PubMed
  171. Zoll PM, Zoll RH, Falk RH, Clinton JE, Eitel DR, Antman EM. External noninvasive temporary cardiac pacing: clinical trials. Circulation. 1985 May; 71(5):937-44. PMID: 3886190.
    View in: PubMed
  172. Falk RH, Lee VW, Rubinow A, Skinner M, Cohen AS. Cardiac technetium-99m pyrophosphate scintigraphy in familial amyloidosis. Am J Cardiol. 1984 Nov 01; 54(8):1150-1. PMID: 6093493.
    View in: PubMed
  173. Falk RH, O'Brien JL. Lorcainide. A comparative trial with quinidine gluconate in patients with previously untreated ventricular arrhythmias. Chest. 1984 Oct; 86(4):537-40. PMID: 6383741.
    View in: PubMed
  174. Falk RH. Clinical application of external pacing. Am J Emerg Med. 1984 May; 2(3):230-1. PMID: 6518018.
    View in: PubMed
  175. Falk RH, Rubinow A, Cohen AS. Cardiac arrhythmias in systemic amyloidosis: correlation with echocardiographic abnormalities. J Am Coll Cardiol. 1984 Jan; 3(1):107-13. PMID: 6317729.
    View in: PubMed
  176. Falk RH, Zoll PM, Zoll RH. Safety and efficacy of noninvasive cardiac pacing. A preliminary report. N Engl J Med. 1983 Nov 10; 309(19):1166-8. PMID: 6621662.
    View in: PubMed
  177. Sullam PM, Falk RH. Cardiac tamponade with refeeding in malnutrition. Am Heart J. 1983 Aug; 106(2):422-3. PMID: 6869231.
    View in: PubMed
  178. Lee VW, Caldarone AG, Falk RH, Rubinow A, Cohen AS. Amyloidosis of heart and liver: comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate for detection. Radiology. 1983 Jul; 148(1):239-42. PMID: 6304810.
    View in: PubMed
  179. Falk RH, Lee VW, Rubinow A, Hood WB, Cohen AS. Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis. Am J Cardiol. 1983 Mar 01; 51(5):826-30. PMID: 6299087.
    View in: PubMed
  180. Falk RH, Hood WB. The heart in sickle cell anemia. Arch Intern Med. 1982 Sep; 142(9):1680-4. PMID: 7114987.
    View in: PubMed
  181. Zelinger AB, Falk RH, Hood WB. Electrical-induced sustained myocardial depolarization as a possible cause for transient ST elevation post-DC elective cardioversion. Am Heart J. 1982 Jun; 103(6):1073-4. PMID: 7081022.
    View in: PubMed
  182. Falk RH, Tarko HB, Levine PA. Positional supraventricular tachycardia. N Engl J Med. 1981 May 28; 304(22):1364. PMID: 7219494.
    View in: PubMed
  183. Falk RH, Mackinnon J, Wainscoat J, Melikian V, Bignell AH. Intravascular haemolysis after valve replacement: comparative study between Starr-Edwards (ball valve) and Björk-Shiley (disc valve) prosthesis. Thorax. 1979 Dec; 34(6):746-8. PMID: 542913; PMCID: PMC471190.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Falk's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_